Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex

Neurobiology of Aging

Volumn 24, Issue 6, 2003, Pages 777-787

  Rees, T ^a   Hammond, P I ^a   Soreq, H ^c   Younkin, S ^b   Brimijoin, S ^a,d  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Amyloid beta 1 42; Amyloid precursor protein; Doubly transgenic mice; Microglial activation; Tg2576

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CD11B ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; THIOFLAVINE; UNCLASSIFIED DRUG;

AGE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BRAIN CORTEX; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HYBRID; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SENILE PLAQUE; STAINING; TRANSGENE; TRANSGENIC MOUSE;

EID: 0038618612     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00230-0     Document Type: Article

References (36)

1. Alvarez A., Opazo C., Alarcon R., Garrido J., Inestrosa N.C. Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrils. J. Mol. Biol. 272:1997;348-361.
2. Beeri R., Andres C., Lev-Lehman E., Timberg R., Huberman T., Shani M.et al. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr. Biol. 5(9):1995;1063-1071.
3. Beeri R., Le Novere N., Mervis R., Huberman T., Grauer E., Changeux J.P.et al. Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. J. Neurochem. 69:1997;2441-2451.
4. Bourne Y., Taylor P., Bougis P.E., Marchot P. Crystal structure of mouse acetylcholinesterase. A peripheral site-occluding loop in a tetrameric assembly. J. Biol. Chem. 274(5):1999;2963-2970.
5. Darboux I., Barthalay Y., Piovant M., Hipeau-Jacquotte R. The structure-function relationships in Drosophila neurotactin show that cholinesterasic domains may have adhesive properties. EMBO J. 15(18):1996;4835-4843.
6. Doody R.S., Dunn J.K., Clark C.M., Farlow M., Foster M., Liao T.et al. Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease. Dement. Geriat. Cogn. Disord. 12(4):2001;295-300.
7. Ellman G.L., Courtney K.D., Andres V. Jr., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
8. Frautschy S.A., Yang F., Irrizarry M., Hyman B., Saido T.C., Hsiao K.et al. Microglial response to amyloid plaques in APPsw transgenic mice. Am. J. Pathol. 152:1998;307-317.
9. Games D., Adams D.et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
10. Geula C., Greenberg B.D., Mesulam M.-M. Cholinesterase activity in the plaques, tangles and angiopathy of Alzheimer's disease does not emanate from amyloid. Brain Res. 644:1994;327-330.
11. Golde T.E., Eckman C.B., Younkin S.G. Biochemical detection of Aβ isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. Biochim. Biophys. Acta. 1502:2000;172-187.
12. Gravina S.A., Ho L., Eckman C.B., Long K.E., Otvos L. Jr., Younkin L.H. et al. J. Biol. Chem. 270(13):1995;7013-7016.
13. Greenblatt H.M., Kryger G., Lewis T., Silman I., Sussman J.L. Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 Å resolution. FEBS Lett. 463:1999;321-326.
14. Higgins L.S., Holtzman D.M., Rabin J., Mobley W.C., Cordell B. Transgenic mouse brain histopathology resembles early Alzheimer's disease. Ann. Neurol. 35:1994;598-607.
15. Holcomb L., Gordon M.N.et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutated amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4(1):1998;97-100.
16. Holtzman D.M., Bales K.R.et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. 97(6):2000;2892-2897.
17. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S.et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
18. Hsiao K.K., Borchelt D.R.et al. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron. 15:1995;1203-1218.
19. Inestrosa N.C., Alvarez A., Perez C.A., Moreno R.D., Vicente M., Linker C.et al. Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron. 16:1996;881-891.
20. Irizarry M.C., McNamara M., Fedorchak K., Hsiao K.K., Hyman B.T. APPsw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56:1997;965-973.
21. Karpel R., Sternfeld M., Ginzberg D., Guhl E., Graessmann A., Soreq H. Overexpression of alternative human acetylcholinesterase forms modulates process extensions in cultured glioma cells. J. Neurochem. 66(1):1996;114-123.
22. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21(2):2001;372-381.
23. Koenigsberger C., Chiappa S., Brimijoin S. Neurite differentiation is modulated in neuroblastoma cells engineered for altered acetycholinesterase expression. J. Neurochem. 69(4):1997;1389-1397.
24. Kryger G., Silman I., Sussman J.L. Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. Structure. 7:1999;297-307.
25. Muller F., Dumez Y., Massoulie J. Molecular forms and solubility of acetylcholinesterase during the embryonic development of rat and human brain. Brain Res. 331(2):1985;295-302.
26. Nilsson L.N.G., Bales K.R., DiCarlo G., Gordon M.N., Morgan D., Paul S.M.et al. α-1-antichymotrypsin promotes β-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's Disease. J. Neurosci. 21(5):2001;1444-1451.
27. Rakonczay Z., Brimijoin S. Monoclonal antibodies to human brain acetycholinesterase: properties and applications. Cell Mol. Neurobiol. 8(1):1988;85-93.
28. Reyes A.E., Perez D.R., Alvarez A., Garrido J., Gentry M.K., Doctor B.P.et al. A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme. Biochem. Biophys. Res. Commun. 232:1997;652-655.
29. Sharma K.V., Koenigsberger C., Brimijoin S., Bigbee J.W. Direct evidence for an adhesive function in the noncholinergic role of acetylcholinesterase in neurite outgrowth. J. Neurosci. Res. 63(2):2001;165-175.
30. Sheng J.G., Mrak R.E., Griffin W.S. Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol. (Berl.). 94:1997;1-5.
31. Shohami E., Kaufer D., Chen Y., Seidman S., Cohen O., Ginzberg D.et al. Antisense prevention of neuronal damages following head injury in mice. J. Mol. Med. 78:2000;228-236. Small D.H., Michaelson S., Sberna G. Non-classical actions of cholinesterases: role in cellular differentiation. Neurochem. Intl. 28(5/6):1996;453-483.
32. Small D.H., Michaelson S., Sberna G. Non-classical actions of cholinesterases: role in cellular differentiation. Neurochem. Intl. 28(5/6):1996;453-483.
33. Soreq H., Seidman S. Acetylcholinesterase - new roles for an old actor. Nat. Rev. Neurosci. 2:2001;294-302.
34. Sturchler-Pierrat C., Abramowski D.et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA. 94:1997;13287-13292. Sussman J.L., Harel M., Silman I. Three-dimensional structure of acetylcholinesterase and of its complexes with anticholinesterase drugs. Chemico-Biol. Int. 87:1993;187-197.
35. Sussman J.L., Harel M., Silman I. Three-dimensional structure of acetylcholinesterase and of its complexes with anticholinesterase drugs. Chemico-Biol. Int. 87:1993;187-197.
36. Suzuki N., Cheung T.T., Cai X-D., Odaka A., Otvos L. Jr., Eckman C.et al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (BAPP717) mutants. Science. 264:1994;1336-1341.